ACSS2 and neoplasm: Decreased ACSS2 expression in colorectal cancer is strongly related to advanced tumor–node–metastasis (TNM) stage, poor differentiation, and cancer recurrence, and is an independent prognostic factor for poor 5-year progression-free survival.